- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent Lung Non-Small Cell Carcinoma in Italy
Total 686 results
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Spain, Hong Kong, Argentina, China, Netherlands, France, Brazil, Belgium, Canada, Germany, Greece, Italy, Japan, Turkey, Ukraine
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, France, Austria, Denmark, Italy, Spain, Germany, Mexico, Netherlands, Japan, Brazil, Greece, Argentina, Slovakia, Lebanon, Belgium, Oman, United Arab Emirates
-
Azienda Ospedaliera Universitaria Integrata VeronaFondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione IRCCS... and other collaboratorsUnknown
-
AmgenRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Australia, Netherlands, Taiwan, Korea, Republic of, United Kingdom, Spain, Austria, Japan, Switzerland, Sweden, France, Czechia, Italy, Portugal, Hong Kong, Thailand, Singapore, Bulgaria, Turkey, Argentina, Belgium, G... and more
-
Hoffmann-La RocheCompletedSquamous Non-Small Cell Lung CancerUnited States, Spain, France, Australia, Germany, Taiwan, Canada, Argentina, Belgium, Singapore, Brazil, Netherlands, Israel, Portugal, Russian Federation, Japan, Italy, Chile, Latvia, Peru, Ukraine, Lithuania, Slovakia, Bulgaria, Mexico, Austri...
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Italy, Korea, Republic of, Spain, Germany, Poland, Switzerland
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCActive, not recruitingBreast Cancer | Non Small Cell Lung CancerUnited States, Spain, France, Belgium, Italy, Taiwan, Turkey
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerAustralia, France, Germany, Spain, China, Hong Kong, Canada, Sweden, Colombia, Taiwan, United Kingdom, Russian Federation, Finland, Austria, Estonia, Hungary, Netherlands, Latvia, Italy, Mexico, Slovenia, Turkey, Bosnia and Herzegovina and more
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
AbbVieCompletedSquamous Non-Small Cell Lung CancerUnited States, Australia, Austria, Belarus, Brazil, Canada, Croatia, Czechia, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, P... and more
-
National Cancer Institute, NaplesAstraZeneca; University of Campania "Luigi Vanvitelli"RecruitingCarcinoma, Non-Small-Cell LungItaly
-
SanofiCompletedCarcinoma, Non-Small-Cell LungItaly
-
Istituto Oncologico Veneto IRCCSTerminatedCarcinoma, Small CellItaly
-
Verastem, Inc.CompletedNon Small Cell Lung Cancer | KRAS Activating MutationUnited States, Spain, France, Germany, Italy
-
Seagen Inc.Merck Sharp & Dohme LLCTerminatedMelanoma | Small Cell Lung Cancer | Prostate Cancer | Gastric Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Gastroesophageal Junction Adenocarcinoma | Non-small Cell Lung Cancer, Squamous | Non-small Cell Lung Cancer, Non-squamousUnited States, Korea, Republic of, Italy, United Kingdom, Australia, Taiwan
-
TakedaActive, not recruitingAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, France, Korea, Republic of, Hong Kong, Australia, Taiwan, United Kingdom, Canada, Turkey, Italy, China, Germany, Japan, Austria, Belgium, Greece, Israel, Netherlands, Portugal, Russian Federation, Singapore, Sw... and more
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Australia, United States, Turkey, Chile, Taiwan, Denmark, France, Spain, Argentina, Italy, Netherlands, Thailand
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina, Korea, Republic of, Germany, Italy, Poland, Belgium, Mexico, Turkey, Spain, France, United States, Canada, Taiwan, Brazil, Austria, Hong Kong, India, Japan, Netherlands, Denmark
-
OSE ImmunotherapeuticsTerminatedNon Small Cell Lung CancerFrance, Spain, Israel, United States, United Kingdom, Italy, Poland, Czechia, Germany, Hungary
-
CelgeneCompletedSquamous Cell Carcinoma, Non-Small-Cell LungUnited States, Spain, Germany, Italy, United Kingdom
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerItaly
-
BayerRecruitingAdvanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationHong Kong, United States, Taiwan, Spain, Belgium, China, Japan, France, Korea, Republic of, Singapore, Poland, Israel, Italy, Netherlands, Portugal, Brazil
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced Non-Small Cell Lung CancerPoland, Russian Federation, United States, Australia, Canada, Hong Kong, Ireland, Italy, Japan, Korea, Republic of, Singapore, South Africa, Spain, Switzerland, Taiwan, United Kingdom
-
Taiho Oncology, Inc.RecruitingNon-Small Cell Lung CancerUnited States, France, Italy, Korea, Republic of, Japan, Spain, Germany, Netherlands, United Kingdom
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerBelgium, Bosnia and Herzegovina, Bulgaria, Egypt, Estonia, Germany, Hungary, Italy, Lithuania, Poland, Romania, Saudi Arabia, Slovakia, Sweden, Taiwan
-
AstraZenecaParexelRecruitingAdvanced or Metastatic Non-Small Cell Lung CancerChina, Netherlands, Korea, Republic of, Italy, Spain, Canada, Hungary, Japan, Argentina, France, United States, Taiwan, Poland, Serbia, United Kingdom, Hong Kong, Brazil, Germany, Belgium, Romania, India, Ireland, Australia
-
PfizerCompletedALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLCUnited States, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republic of, Spain, Belgium, Switzerland, France, Germany, Hong Kong, Italy
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellCanada, Italy, Belgium, France, Germany, United Kingdom
-
Janssen Research & Development, LLCRecruitingCarcinoma, Non-small-Cell LungUnited States, Korea, Republic of, Italy, Israel, Malaysia, United Kingdom, China, Brazil, Spain, Germany, Japan, France
-
Hoffmann-La RocheCompletedNon-small Cell Lung CancerBelgium, Italy, Portugal, Spain, Germany, Turkey, France, Hong Kong, Korea, Republic of, Poland, Russian Federation, Hungary, Norway, Bulgaria, Slovakia
-
Mirati Therapeutics Inc.Bristol-Myers SquibbActive, not recruitingMetastatic Non-Squamous Non-Small Cell Lung CancerUnited States, Canada, Belgium, France, Germany, Hungary, Israel, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
IRCCS Azienda Ospedaliera Universitaria San Martino...Unknown
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaActive, not recruitingAdvanced or Metastatic NSCLCUnited States, Spain, Taiwan, Japan, Italy
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedFirst Line Non-Small Cell Lung CancerSpain, United States, Hungary, Israel, China, Korea, Republic of, Taiwan, Czechia, Russian Federation, Australia, Brazil, Lebanon, Serbia, Thailand, Canada, Slovakia, Ukraine, Bulgaria, Italy, Netherlands, New Zealand, Poland, Belgium, Turk... and more
-
University of Milano BicoccaRecruiting
-
Eli Lilly and CompanyAventis PharmaceuticalsCompleted
-
Daiichi SankyoAstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Spain, Korea, Republic of, Italy, France, Japan, Taiwan, Netherlands, Australia, Canada
-
European Organisation for Research and Treatment...CompletedLung CancerUnited Kingdom, Belgium, Netherlands, Italy, France
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, France, Sweden, Germany, Italy
-
SanofiActive, not recruitingNon-small Cell Lung Cancer MetastaticGreece, Italy, Hungary, Belgium, Korea, Republic of, Turkey, Argentina, China, Spain, Chile, Poland, Australia, United States, Russian Federation, Brazil, Bulgaria, Canada, France, Germany, India, Israel, Japan, Lithuania, Mexico, Nethe... and more
-
Xcovery Holdings, Inc.Active, not recruitingNon-small Cell Lung CancerSpain, United States, China, Korea, Republic of, Hong Kong, United Kingdom, Poland, Israel, Germany, France, Argentina, Australia, Brazil, Canada, Czechia, Italy, Netherlands, Russian Federation, Turkey, Belgium
-
Novartis PharmaceuticalsCompletedNon-Small-Cell Lung CancerGreece, Taiwan, Germany, Belgium, Italy, Spain, United Kingdom, Korea, Republic of, Netherlands, China, Hungary, Poland, France, Thailand, Portugal
-
Bristol-Myers SquibbCompletedCarcinoma, Non-Small-Cell Lung | Small Cell Lung Cancer | Lung CancerUnited States, India, Italy, France, Germany, Poland, Russian Federation, Ukraine
-
Janssen Research & Development, LLCActive, not recruitingAdvanced or Metastatic Non-small Cell Lung CancerItaly, United States, Germany, Japan, China, Korea, Republic of, Israel, Portugal, Taiwan, Thailand, Malaysia, United Kingdom, Australia, Turkey, Poland, Spain, Brazil, Canada, Argentina, France
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerChina, Korea, Republic of, South Africa, Taiwan, Hungary, France, Netherlands, United States, Bulgaria, Slovakia, Canada, Italy, Brazil, Thailand, Romania, Lithuania, Poland, Latvia, Ukraine, Czech Republic
-
Spanish Lung Cancer GroupCompletedNon-Small Cell Lung CancerSpain, France, Italy
-
Eisai Inc.Quintiles, Inc.CompletedNon-Small Cell Lung CancerBelgium, Korea, Republic of, Italy, United States, Hungary, United Kingdom, Czechia
-
Daiichi SankyoActive, not recruitingEGFR L858R | EGFR Exon 19 Deletion | Nonsquamous Non-small Cell Lung CancerKorea, Republic of, United States, Netherlands, Spain, United Kingdom, Japan, Austria, Belgium, Italy, France, Taiwan, Germany, Australia, Singapore, China, Hong Kong, Norway, Canada, Poland, Portugal, Switzerland
-
Novartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerItaly, Singapore, Spain, Germany, Korea, Republic of, United States, Belgium, France, Netherlands, Japan
-
European Institute of OncologyUnknownLung CancerItaly, Korea, Republic of, Greece